Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.
2.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

PMID:
19752408
3.

Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly.

Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F.

Heart Rhythm. 2008 May;5(5):646-53. doi: 10.1016/j.hrthm.2008.01.038.

PMID:
18452864
4.

Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.

Ding L, Hua W, Niu H, Chen K, Zhang S.

Europace. 2008 Sep;10(9):1034-41. doi: 10.1093/europace/eun150. Review.

5.
6.

The implantable cardioverter defibrillator.

Rinaldi CA, Gill JS.

Hosp Med. 2002 Nov;63(11):672-5. Review.

PMID:
12474612
7.
8.

Cardioverter-defibrillator in the primary prevention of sudden death: for all or for a few?

Zimerman LI.

Arq Bras Cardiol. 2008 Aug;91(2):63-4. English, Portuguese. No abstract available.

9.

[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].

Francia P, Cappato R.

G Ital Cardiol (Rome). 2011 May;12(5):379-82; discussion 382. doi: 10.1714/643.7504. Italian. No abstract available.

PMID:
21593958
10.

Cost-effectiveness of cardioverter-defibrillators in heart failure patients.

Gandjour A.

Europace. 2009 Dec;11(12):1721. doi: 10.1093/europace/eup327. No abstract available.

11.

The economic burden of heart failure and implantable cardioverter defibrillators: The value of noninvasive imaging of high-risk patients.

Chambers MG, Narula J, Cerqueira MD.

J Nucl Cardiol. 2002 Sep-Oct;9(5 Suppl):71S-80S. No abstract available.

PMID:
12271267
12.

The cost of implantable defibrillators: perceptions and reality.

Camm J, Klein H, Nisam S.

Eur Heart J. 2007 Feb;28(4):392-7. Review.

13.

The cost of implantable defibrillators: how the perception of reality depends on perspective.

Heidb├╝chel H.

Eur Heart J. 2007 Feb;28(4):386-7. No abstract available.

14.

The evolution and revolution of the implantable cardioverter defibrillator.

Indik JH.

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):461-4. No abstract available.

PMID:
15225105
15.

Transvenous implantable cardioverter-defibrillator leads: the weakest link.

Maisel WH.

Circulation. 2007 May 15;115(19):2461-3. No abstract available.

16.

A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

Tung R, Zimetbaum P, Josephson ME.

J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058. Review.

17.

Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.

de Bie MK, Lekkerkerker JC, van Dam B, Gaasbeek A, van Buren M, Putter H, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW.

Curr Med Res Opin. 2008 Aug;24(8):2151-7. doi: 10.1185/03007990802237343.

PMID:
18561878
18.

Cost-effectiveness of implantable cardioverter-defibrillators.

Boriani G, Biffi M, Martignani C, Gallina M, Branzi A.

Eur Heart J. 2001 Jun;22(12):990-6. No abstract available.

19.

Primary prevention implantable cardioverter-defibrillators: economics and ethics.

Silver MT.

Am Heart Hosp J. 2005 Summer;3(3):205-6. No abstract available.

PMID:
16106144
20.

Current status of implantable cardioverter-defibrillators.

O'Callaghan PA, Ruskin JN.

Curr Probl Cardiol. 1997 Dec;22(12):641-707. Review. No abstract available.

PMID:
9442981
Items per page

Supplemental Content

Support Center